Tumor-infiltrating neutrophils in pancreatic neoplasia

Modern Pathology

Volumn 24, Issue 12, 2011, Pages 1612-1619

  Reid, Michelle D ^a   Basturk, Olca ^b   Thirabanjasak, Duangpen ^c   Hruban, Ralpha H ^d   Klimstra, David S ^b   Bagci, Pelin ^a   Altinel, Deniz ^a   Adsay, Volkan ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

neoplasms; pancreatic; tumor infiltrating neutrophils

Indexed keywords

MUCIN 1;

ARTICLE; CARCINOGENESIS; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; NEUTROPHIL; NEUTROPHIL COUNT; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PRIORITY JOURNAL; TUMOR CLASSIFICATION; TUMOR INFILTRATING NEUTROPHIL;

ADENOCARCINOMA, MUCINOUS; CARCINOMA; CARCINOMA IN SITU; CARCINOMA, ACINAR CELL; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; CYSTADENOMA, SEROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MUCIN-1; NEOPLASM INVASIVENESS; NEUTROPHIL INFILTRATION; NEUTROPHILS; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 82555191059     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.113     Document Type: Article

References (29)

1. Di Carlo E, Forni G, Lollini P, et al. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001;97:339-345. (Pubitemid 32060315)
2. Dallegri F, Ottonello L, Ballestrero A, et al. Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. Inflammation 1991;15:15-30.
3. Kindzelskii AL, Petty HR. Early membrane rupture events during neutrophil-mediated antibody-dependent tumor cell cytolysis. J Immunol 1999;162:3188-3192. (Pubitemid 29313564)
4. Aeed PA, Nakajima M, Welch DR. The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762NF mammary adeno-carcinoma cells. Int J Cancer 1988;42:748-759. (Pubitemid 19008920)
5. Welch DR, Schissel DJ, Howrey RP, et al. Tumor-elicited polymorphonuclear cells, in contrast to 'normal' circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci USA 1989; 86:5859-5863. (Pubitemid 19217548)
6. Bellocq A, Antoine M, Flahault A, et al. Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol 1998;152:83-92. (Pubitemid 28028049)
7. Apple SK. Invasive ductal carcinoma with tissue neutrophilia: a distinct entity? Breast (Edinburgh, Scotland) 2004;13:519-521. (Pubitemid 39618826)
8. Caruso RA, Bellocco R, Pagano M, et al. Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol 2002;15:831-837. (Pubitemid 34919775)
9. Fossati G, Ricevuti G, Edwards SW, et al. Neutrophil infiltration into human gliomas. Acta Neuropathologica 1999;98:349-354. (Pubitemid 29440680)
10. Rice AJ, Griffiths AP, Martin IG, et al. Gastric carcinoma with prominent neutrophil infiltration. Histopathology 2000;37:289-290.
11. Wislez M, Fleury-Feith J, Rabbe N, et al. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating broncho-alveolar subtype pulmonary adenocarcinoma. Am J Pathol 2001;159:1423-1433. (Pubitemid 32947972)
12. Wislez M, Rabbe N, Marchal J, et al. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarci-noma: role in tumor progression and death. Cancer Res 2003;63:1405-1412. (Pubitemid 36348724)
13. Nielsen HJ, Hansen U, Christensen IJ, et al. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 1999;189:487-495.
14. Musiani P, Allione A, Modica A, et al. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Lab Invest 1996;74:146-157.
15. Matsumoto Y, Saiki I, Murata J, et al. Recombinant human granulocyte colony-stimulating factor inhibits the metastasis of hematogenous and non-hematogen-ous tumors in mice. Int J Cancer 1991;49:444-449.
16. Khayyata S, Basturk O, Adsay NV. Invasive micro-papillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils. Mod Pathol 2005;18:1504-1511. (Pubitemid 41509406)
17. Beatty PL, Plevy SE, Sepulveda AR, et al. Cutting edge: transgenic expression of human MUC1 in IL-10-/-mice accelerates inflammatory bowel disease and progression to colon cancer. J Immunol 2007;179:735-739.
18. Satoh S, Hinoda Y, Hayashi T, et al. Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule. Int J Cancer 2000;88:507-518.
19. Nassar H, Pansare V, Zhang H, et al. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein. Mod Pathol 2004;17:1045-1050. (Pubitemid 39128230)
20. Westgaard A, Schjolberg AR, Cvancarova M, et al. Differentiation markers in pancreatic head adenocar-cinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours. Histopathology 2009;54:337-347.
21. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002;15:1087-1095.
22. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an 'intestinal' pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004;28:839-848. (Pubitemid 38856838)
23. Datta A, Bryant DM, Mostov KE. Molecular regulation of lumen morphogenesis. Curr Biol 2011;21:R126-R136.
24. Levi E, Klimstra DS, Andea A, et al. MUC1 and MUC2 in pancreatic neoplasia. J Clin Pathol 2004;57:456-462. (Pubitemid 38621788)
25. Kadayakkara DK, Beatty PL, Turner MS, et al. Inflammation driven by overexpression of the hypoglycosylated abnormal mucin 1 (MUC1) links inflammatory bowel disease and pancreatitis. Pancreas 2010;39:510-515.
26. Ryan SO, Vlad AM, Islam K, et al. Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice. Biol Chem 2009;390:611-618.
27. Carlos CA, Dong HF, Howard OM, et al. Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity. J Immunol 2005;175:1628-1635. (Pubitemid 41023065)
28. Yonezawa S, Higashi M, Yamada N, et al. Significance of mucin expression in pancreatobiliary neoplasms. J Hepato-Biliary-Pancreat Sci 2010;17:108-124.
29. Rodriguez IM, Irving JA, Prat J. Endocervical-like mucinous borderline tumors of the ovary: a clinico-pathologic analysis of 31 cases. Am J Surg Pathol 2004;28:1311-1318. (Pubitemid 39336369)